Loop Capital analyst Joseph France raised the firm’s price target on UnitedHealth to $600 from $590 and keeps a Buy rating on the shares. The company’s Q1 results saw "solid upside" and its guidance raise for FY23 was "conservative", as UnitedHealth attraction has likely "increased considerably" in recent weeks, the analyst tells investors in a research note. Given its leading Star ratings, growing range of services and expanding provider network, UnitedHealth’s value-based care platform should continue driving revenue and earnings, Loop Capital added.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UNH:
- Rob Arnott Says It’s Time to Buy Into Value Stocks; Here Are 2 Names That Analysts Like
- UnitedHealth says Optum RX experienced another strong growth season
- UnitedHealth Gains after Q1 Earnings Beat and Raised Outlook
- UnitedHealth raises FY23 adjusted EPS view to $24.50-$25.00 from $24.40-$24.90
- UnitedHealth reports Q1 adjusted EPS $6.26, consensus $6.13